Monthly Archives: August 2017

Emulating Endowments With ETFs

ETF.com posted an interview with Hossein Kazemi from Chartered Alternative Investment Analyst Association who did a study that concluded that small and medium sized endowments can effectively compete with the larger endowments by using ETFs to replicate the non-market based alternative strategies that funds like Harvard and Yale are known for and getting very similar return streams…

Looming American Debt Ceiling Crisis

The U.S. government is getting closer and closer to running out of cash… for real this time. The government has until the end of September to raise the U.S. debt ceiling – that is, the total amount the government is allowed to borrow. Otherwise, it won’t be able to pay its bills. The U.S. government…

Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval

Novartis AG (NVS – Free Report) announced that the FDA has approved its breakthrough gene transfer treatment, Kymriah (tisagenlecleucel) suspension for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse. Kymriah, formerly CTL019, is the first chimeric antigen receptor T cell…

The Big Four Economic Indicators: Real Personal Income In July

Note: This commentary has been updated to include this morning’s release of the July data for Real Personal Income Less Transfer Receipts. Official recession calls are the responsibility of the NBER Business Cycle Dating Committee, which is understandably vague about the specific indicators on which they base their decisions. This committee statementis about as close as they…